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nogram are compared. A threshold based on the NREM data 
is used to identify a subject-specific threshold for abnormality 
in the REM variance. A metric that includes the percentage of 
REM variance exceeding the threshold relates to RBD. 
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AUTOMATED POLYSOMNOGRAPHIC 
ASSESSMENT FOR RAPID EYE MOVEMENT 
SLEEP BEHAVIOR DISORDER 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
2 
during the REM sleep time interval or the percentage may be 
used in conjunction with a visual PSG score and/or clinical 
impression to assess RBD. 
Further areas of applicability will become apparent from 
5 the description provided herein. It should be understood that 
the description and specific examples are intended for pur-
poses of illustration only and are not intended to limit the 
scope of the present disclosure. This application claims the benefit of U.S. Provisional 
Application No. 60/921,466, filed on Apr. 2, 2007. The dis-
closure of the above application is incorporated herein by 10 
reference. 
DRAWINGS 
GOVERNMENT RIGHTS 
This invention was made with govermnent support under 15 
Contract Nos. POI NS! 5655 and MO! RR000042 awarded by 
the National Institutes of Health. The government has rights 
FIG. 1 is a flowchart ofa method for diagnosing and assess-
ing rapid eye movement sleep behavior disorder (RBD) in a 
patient according to one embodiment of the present disclo-
sure; 
FIG. 2 is a block diagram of a system for diagnosing and 
assessing rapid eye movement sleep behavior disorder (RBD) 
in a patient constructed according to one embodiment of the 
present disclosure; 
in the invention. 
FIELD 
The present disclosure relates to methods and systems for 
diagnosing and assessing rapid eye movement sleep behavior 
disorder and related conditions. 
INTRODUCTION 
Rapid eye movement (REM) sleep behavior disorder 
(RBD) affects about 0.4% of adults, 0.5% of older adults, 
33% of patients with newly diagnosed Parkinson's Disease, 
and 90% of patients with multiple system atrophy. Conse-
quences can include injury to the patient, threats to the safety 
of a bed partner, and inability to share a bed with a partner. 
Diagnosis is important because the condition responds well to 
treatment, most often with clonazepam. Moreover, RBD may 
be a harbinger for neurodegenerative conditions such as Par-
kinson's disease (PD), multiple system atrophy (MSA), or 
dementia with Lewy bodies (DLB), which together comprise 
the alpha-synucleinopathies. In the absence of RBD, REM 
sleep without atonia may also signal increased risk for alpha-
synucleinopathies. 
20 FIG. 3 graphically illustrates a thirty-second epoch of 
REM sleep (upper panel), along with a corresponding plot of 
calculated EMG variance for each 3-second mini-epoch 
(lower panel); 
FIG. 4 graphically illustrates electromyographic variance 
25 computed over 3-second mini-epochs through the night (A) 
for a subject without a clinical diagnosis ofRBD, and (B) for 
a subject with a clinical diagnosis of RBD; 
FIG. 5 graphically illustrates that the computer-generated 
Supra-Threshold REM EMG Activity Metric (STREAM) 
30 correlates closely with the visually-based polysomnographic 
score for RBD severity; 
FIG. 6 graphically illustrates that the computer-generated 
EMG variance score (A) and visually-generated PSG score 
(B) show similar ability to separate subjects for whom RBD 
35 was considered probable or possible (1) or unlikely (0) by 
clinicians who interviewed and examined the subjects; 
FIG. 7 graphically illustrates RBD symptom scores 
derived from an International Criteria for Sleep Disorders-
based questionnaire plotted against the computer-generated 
40 STREAM score (A) and the visually-generated PSG score 
(B); 
FIG. 8 graphically illustrates receiver-operator character-
istic (ROC) curves for the STREAM and the visually-gener-
ated PSG score; 
There is a need for improved methods and systems for the 
diagnosis of RBD, and for assessment of RBD-like features 
that may predict future development of neurodegenerative 
disorders. The statements in this section merely provide back- 45 
ground information related to the present disclosure and may 
not constitute prior art. 
FIG. 9 graphically illustrates that the STREAM during 
REM sleep on night 1 correlates with STREAM on night 2; 
FIG.10 graphically illustrates a quantitative visual scoring 
method where the RBD polysonmographic score (PSG 
Score) is plotted against the International Classification of 
50 Sleep Disorders-based clinical impression of RBD presence 
(1) or absence (0); and 
SUMMARY 
The present disclosure includes methods and systems 
related to assessment of rapid eye movement sleep behavior 
disorder and related conditions. 
FIG. 11 graphically illustrates a quantitative visual scoring 
method where the REM (rapid eye movement) sleep behavior 
disorder (RBD) polysonmographic score (PSG score) is plot-
55 ted against the RBD symptom score derived from bed partner 
questionnaires (Quest). 
In some embodiments, the present disclosure relates to a 
method for diagnosing and assessing rapid eye movement 
sleep behavior disorder (RBD) in a patient. The method 
includes measuring at least one physiological signal of the 
patient during at least one rapid eye movement (REM) sleep 
time interval and at least one non-rapid eye movement 
(NREM) sleep time interval. The method also includes deter- 60 
mining a Variance for the physiological signal within at least 
one REM sleep time interval and a variance for the physi-
ological signal within at least one NREM sleep time interval. 
A threshold based on the NREM variance is established and a 
percentage of REM sleep time intervals with variance above 65 
the threshold is calculated. The patient may be classified as an 
RBD candidate when the percentage exceeds the threshold 
The drawings described herein are for illustration purposes 
only and are not intended to limit the scope of the present 
disclosure in any way. 
DETAILED DESCRIPTION 
Polysonmography is a valuable technique in the diagnosis 
of rapid eye movement sleep behavior disorder (RBD) and in 
identifying REM sleep without atonia, but interpretation of 
the requisite findings can be highly subjective. In many cases, 
dream enactment is not directly observed in the sleep labora-
US 7,996,076 B2 
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tory. Diagnosis may depend on the polysomnographer's per-
ception of elevated baseline muscle tone or abnormally fre-
quent bursts of discrete muscle activation recorded from the 
surface electromyogram (EMG) during REM sleep. Diagno-
sis based on quantification of these EMG patterns, or some 5 
objective polysomnographic measure ofRBD severity, is less 
subjective and more reliable. 
In some embodiments, the present disclosure provides 
methods and systems to quantify polysomnographic evidence 
of RBD severity; to help assess risk for RBD at present; to 10 
help assess risk for development ofRBD in the future; and/or 
to help assess the extent to which physiologic features of 
RBD are present on the polysomnogram. Embodiments may 
include a computer algorithm to identify EMG features of 
RBD automatically. The computerized algorithm identifies 15 
polysomnographic evidence of RBD as accurately as visual 
scoring methods, including those performed by a polysom-
nographer and including the methods described by Lapierre 
0, Montplaisir J., "Polysomnographic features ofREM sleep 
behavior disorder: Development of a scoring method," Neu- 20 
rology 1992; 42:1371-1374 and Consens F B, Chervin RD, 
Koeppe RA et al., "Validation of a polysomnographic score 
for REM sleep behavior disorder," Sleep 2005; 28(8):993-
997. The present methods and visual scoring methods show 
similar correspondence to clinical and questionnaire evi- 25 
dence ofRBD. 
4 
tone during REM sleep should not exceed the lowest tone 
noted during non-REM sleep, operationalized here as the 5th 
percentile of the NREM EMG variance. To identify activity 
likely to be abnormal, with reference to NREM EMG tone, 
the abnormality threshold may be set at 4 times the 5th per-
centile. Other cut-offs may perform similarly; e.g., 2 to 6 
times the 5th percentile. The choice for a specific cut-off is in 
no way meant to exclude other choices that can reasonably be 
made without alteration of the underlying methodological 
concept. This underlying concept is that a patient-specific 
EMG variance threshold during REM sleep may be automati-
cally computed (rather than visually and subjectively 
assessed) for an individual patient based on that same 
patient's muscle tone during sleep more generally, or particu-
larly during non-REM sleep. 
In some embodiments, the percentage of REM mini-ep-
ochs with variance above the selected threshold is computed 
as a metric for assessing RBD. The percentage of all REM 
mini-epochs with variance above this threshold is also 
referred to in the present disclosure as the Supra-Threshold 
REM EMG Activity Metric (STREAM), which may be deter-
mined for each patient. A score for each patient may be 
calculated as a REM sleep duration-weighted average of 
results over the course of two or more nights. However, 
STREAM may also be determined based on one night of 
recording, part of one night, or multiple nights. Other meth-
ods and techniques that compare and/or contrast the variabil-
In some embodiments, an automated method is provided 
that facilitates objective identification ofRBD based on sleep 
studies, including, for example, polysomnograms. The 
method may include recording one or more electromyogram 
(EMG) signals (non-invasive or invasive) for a subject while 
the subject is sleeping. It is envisioned that other physiologi-
cal signals indicative of muscle activity during sleep, such as 
cardiac-related signals, may be used in place ofEMG signals. 
30 ity of the EMG signal in REM sleep versus NREM sleep may 
be used. These other methods and techniques may be used to 
establish a threshold for assessment of RBD. Thus, various 
means for determining the variability of the EMG signal 
between REM and NREM sleep can be used in the present 
Portions of the EMG signal(s) that are recorded during 
REM sleep are identified. For example, 30-second epochs of 
REM sleep may be identified using a standard visual scoring 
method. However, REM sleep phases may be identified either 
35 methods and systems. 
With reference to FIG. 1, a flowchart is shown that dia-
grams a method for diagnosing and assessing rapid eye move-
ment sleep behavior disorder (RBD) in a patient. With respect 
to reference numeral 100, one or more physiological signals 
of a patient are measured during REM and NREM sleep 
intervals. These physiological signals may include signals 
obtained using one or more of the following: electroencepha-
logram (EEG), electromyogram (EMG), electrooculogram 
(EOG), electrocardiogram (ECG), snoring, respiratory effort, 
airflow at the nose and mouth, pulse oximetry, and combina-
tions thereof. In addition to these, other physiological signals 
that differ between wakefulness, REM sleep, and NREM 
sleep may be suitable for use in the method; for example, 
in this manner or by using automated signal analysis tech-
niques. For example, an automated method for distinguishing 40 
REM and NREM sleep intervals may include using the Mor-
pheus® Clinical Sleep Information System (WideMed, Ltd., 
Herzliya, Israel). The automated method for distinguishing 
REM and NREM sleep may be used concurrently with the 
present methods to collect and process various physiological 45 
signals, including one or more of the following: electroen-
cephalogram (EEG), electromyogram (EMG), electrooculo-
gram (EOG), and electrocardiogram (ECG), or other physi-
ological signals indicative of wakefulness, REM sleep, and 
NREM sleep. 50 other physiological signals indicative of muscle activity may 
be used. Signals may also be obtained from multiple locations 
using the same technique. For example, EMG signals may be 
measured at the chin, forearm extensor compartments, and 
the anteriortibialis muscles bilaterally, including surface and/ 
In some embodiments, the EMG signal is partitioned into 
predefined time increments (e.g., 3 second mini-epochs) and 
a variance measure is calculated for each time increment. The 
variance of n data samples x, may be computed as 
55 or subsurface measurement. 
n n 
(l/(n-1)) ~ (x; -xi, where x = (1/n) ~x;. 
i=l i=l 
With respect to reference numeral 110, the physiological 
signal may be filtered to reduce background noise and/or to 
select particular frequencies for analysis. Specific EMG fre-
60 quency bands may prove more useful than others. For 
example, the lower frequency bands (e.g., 10 to 15 Hz) may 
be more useful in some cases, and even frequencies lower 
than 10 Hz may be used. 
It is also contemplated that an alternative measure of EMG 
variability may be used. An abnormality threshold for the 
EMG signal variance occurring during REM sleep may be 
established based on the EMG variance observed during the 
NREM portion of sleep. For example, the abnormality thresh- 65 
old may be set at four times the 5th percentile of the variance 
observed during the NREM time intervals. Normally, EMG 
With respect to reference numeral 120, the time-evolution 
of the variance is determined for the EMG signal within at 
least one REM sleep time interval and the background level of 
the variance is determined for the EMG signal within at least 
US 7,996,076 B2 
5 
one NREM sleep time interval. These variances may deter-
mined by using the formula: 
N 
CT= 1/(N -1) ~(x; -xi 
i=l 
wherein a is the variance, N is the number of samples in the 
time interval, x, is the ith sample of the signal in the time 
interval, and x is signal in the time interval. Alternatively, 
variances may be determined by calculating the sum of the 
square amplitudes of the physiological signals within the 
REM sleep time interval. Other techniques for computing the 
variability of the signal over time are contemplated by this 
disclosure. 
6 
The processor 250 includes a software-implemented algo-
rithm capable of determining a rapid eye movement (REM) 
variance for the physiological signals within at least one REM 
sleep time interval and a non-rapid eye movement (NREM) 
5 variance for physiological signals within the at least one 
NREM sleep time interval, establishing a threshold based on 
the NREM variance, and calculating a percentage of REM 
sleep time intervals with variance above the threshold. The 
time-evolution of the variance may be determined for the 
10 EMG signal within at least one REM sleep time interval and 
the background level of the variance may be determined for 
the EMG signal within at least one NREM sleep time interval. 
It is to be understood that only the relevant steps of the 
algorithm are discussed in relation to FIG. 1, but that other 
15 software-implemented instructions may be needed to control 
and manage the overall operation of the system. The algo-
rithm or portions of the algorithm may be stored on one or 
more types of computer-readable medium associated with the With respect to reference numeral 130, a threshold is estab-
lished based on the NREM variance. For example, the thresh-
old can be set as the upper limit for the physiological signal 20 
background during REM sleep, with the upper limit being 
about two to about six times the 5th percentile of the NREM 
varrnnce. 
instrument 220 and/or the processor 250. 
The processor 250 also includes a signal output device to 
output to a user the REM and NREM variances, the threshold, 
and/or the calculated percentage of REM sleep time intervals 
with variance above the threshold. As shown in FIG. 2, the 
output device may be the screen of the laptop computer. The With respect to reference numeral 140, a percentage of 
REM sleep time intervals with variance above the threshold is 
calculated. For example, where the signals are EMG signals, 
the method includes calculating the Supra-Threshold REM 
EMG Activity Metric (STREAM). In addition, various EMG 
signals may be used, such as EMG signals other than surface 
chin EMG. The EMG may be recorded from any muscle or 
multiple muscles, and by means other than surface record-
ings. It should be appreciated that the calculations described 
for STREAM in the present disclosure can be applied to 
determine analogous metrics for various other techniques that 
measure physiological signals indicative of muscle activity. 
Thus, when the present disclosure contemplates methods or 
systems using STREAM, these analogous metrics for muscle 
activity may be included in addition to or substituted for 
STREAM. 
The percentage or proportion calculated at reference 
numeral 140 may be used to classify the patient as a candidate 
for rapid eye movement sleep behavior disorder (RBD), as 
indicated at reference numeral 150. Alternatively, or in addi-
tion to, as shown at reference numeral 160, the percentage or 
proportion may be used in conjunction with other assess-
ments of RBD, such as visual PSG scoring and/or clinical 
impressions collected via questionnaires, for example. Alter-
natively, the percentage or proportion may simply be used as 
a continuous score for characterization of the subject's physi-
ologic RED-tendency, rather than as a dichotomous score to 
label a patient as having or not having RBD. 
With reference to FIG. 2, a system is shown for diagnosing 
and assessing rapid eye movement sleep behavior disorder 
(RBD) in a patient. The sleeping patient 200 is connected 210 
to an instrument 220 that acts as a signal input device to 
collect one or more physiological signals, for example an 
electromyograph. The physiological signals may be pro-
cessed in some manner by the instrument 220. For example, 
the instrument 220 may filter particular signal frequencies. 
The instrument 220 ( or signal input device) is connected to a 
processor 250, which as shown in FIG. 2 may be part of a 
laptop computer. Alternatively, the instrument 220 that col-
lects the signals and the processor 250 may be a single unit, 
where as shown by reference numeral 240, the physiological 
signals from the patient 200 are received directly by the 
combination processor 250 and signal input device. 
25 output may also be stored or transmitted via a network to a 
remote user. The processor 250 may include multiple algo-
rithms that perform various methods described by the present 
disclosure. 
Methods and systems employing the algorithm, perfor-
30 mance and output of the algorithm, and determination of one 
or more STREAM values are illustrated by application of 
these methods and systems to a group of23 subjects. Subjects 
(n=23) may be identified and recruited as described by Con-
sens et al. in "Validation of a polysonmographic score for 
35 REM sleep behavior disorder" Sleep 2005; 28(8):993-997. 
Seventeen subjects are patients and six are control subjects. 
The seventeen patients carried diagnoses of multiple system 
atrophy (MSA, n=5), Parkinson's disease (PD, n=6), demen-
tia with Lewy bodies (DLB, n=2), progressive supranuclear 
40 palsy (n=3), and sporadic olivopontocerebellar atrophy 
(n=l). Patients with progressive supranuclear palsy are 
included to have a group of patients with a neurodegenerative 
disorder causing Parkinsonian symptoms unassociated with 
RBD, for comparison with the MSA, PD, and DLB patients. 
45 Diagnoses are established by board-certified neurologists 
who specialize in neurodegenerative disorders. A consulta-
tion with sleep medicine specialists may be included as part of 
the protocol. Normal control subjects, without any specific 
sleep complaints and with no genetic relationship to the 
50 patients, had similar age and sex distributions to those of the 
patients. 
Histories, physical examinations, and polysonmograms 
are performed as follows. Sleep-oriented clinical histories are 
performed by either of 2 physicians, board-certified in both 
55 sleep medicine and neurology, who are masked to any ques-
tionnaire and polysonmographic data. Based on widely-used 
clinical criteria (as described in American Sleep Disorders 
Association, "International classification of sleep disorders, 
revised: Diagnostic and coding manual," Rochester, Minn.: 
60 American Sleep Disorders Association, 1997), which at that 
time did not require polysonmography to assess for RBD, the 
likelihood of the diagnosis is rated as probable (2), possible 
(1 ), or unlikely (0). Patients with a history of frequent, clear 
dream enactment are rated as "probable," those without noc-
65 turnal behavioral episodes as "unlikely," and those with such 
episodes that are not clearly dream enactment are rated as 
"possible." Seven subjects had a clinical impression of prob-
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able RBD, and for purposes of analyses these are combined 
with the two subjects who had possible RBD. 
Bed partners completed a questionnaire that asked for Lik-
ert scale ratings for each of the symptoms that are diagnostic 
criteria for RBD, as per American Sleep Disorders Associa- 5 
tion, "International classification of sleep disorders, revised: 
Diagnostic and coding manual," Rochester, Minn.: American 
Sleep Disorders Association, 1997. Results are tallied and 
averaged to determine an overall RBD symptom score that 
could range from Oto 1.0. 10 
All subjects underwent laboratory-based polysonmogra-
phy (PSG) for two consecutive nights. Digital recordings 
included electroencephalogram (EEG) (C3-A2, C4-Al, 
O1-A2, O2-Al by International 10-20 system), chin elec- 15 
tromyogram (EMG), electrooculogram (EOG), electrocar-
diogram, snoring, respiratory effort using piezoelectric belts 
over the chest and abdomen, airflow at the nose and mouth 
using thermocouples, and pulse oximetry. Surface EMGs are 
recorded from the forearm extensor compartments and the 20 
anterior tibialis muscles bilaterally. The data are collected 
using Telefactor digital polysonmography equipment (Con-
shohocken, Pa.). The EMG is recorded with a 10 Hz high-pass 
filter and a 60 Hz notch filter, and sampled at 200 Hz. A digital 
10-70 Hz band pass filter is applied to the EMG data before 25 
subsequent computer processing. Experienced polysonmo-
graphic technologists masked to patient diagnoses applied the 
electrodes, monitored the studies continuously, and moni-
tored the subjects by continuous video observation. 
Polysomnograms are scored manually according to a stan- 30 
dard protocol, as described in Rechtschaffen A, Kales A, "A 
manual of standardized terminology, techniques and scoring 
system for sleep stages of human subjects," Los Angeles: 
Brain Information Service/Brain Research Institute, UCLA, 35 
1968. In addition, one senior registered polysonmographic 
technologist masked to patients' clinical data manually (visu-
ally) scored PSG measures of RBD in accordance with the 
approach described by Lapierre 0, Montplaisir J., "Polysom-
nographic features of REM sleep behavior disorder: Devel- 40 
opment of a scoring method," Neurology 1992; 42:1371-
1374. The approach is based on two measurements: the 
proportion of 20-second REM sleep epochs that contain a 
predominance of abnormally elevated background chin 
muscle tone (tonic component), and the proportion of 2-sec- 45 
ond mini-epochs (within 20-second REM sleep epochs) that 
show bursts of EMG activity (phasic component). Identical 
measures are used with the present methods, except that the 
epochs to assess tonic activity are 30 seconds in duration (a 
more widely used standard), and the mini-epochs to assess 50 
phasic activity are 3 seconds in duration. Each REM sleep 
epoch is scored as tonic or atonic depending on whether tonic 
chin EMG activity is present for more or less than 50% of the 
epoch. 
"Percent phasic" and "percent tonic" scores for each sub- 55 
ject are computed as a REM sleep duration-weighted average 
of the results from the two nights, in a manner that essentially 
considered the data from the two recordings as if they are 
obtained from one long night. The percent phasic and percent 
tonic scores are then averaged to obtain an overall "PSG 60 
score" that reflects results of the visually-assessed method 
described by Lapierre 0, Montplaisir J., "Polysonmographic 
features of REM sleep behavior disorder: Development of a 
scoring method," Neurology 1992; 42:1371-1374. 
A computer algorithm is used to calculate the variance of 65 
the chin EMG signal during all 3-s mini-epochs within each 
PSG. The variance a is computed as: 
8 
N 
CT= 1/(N -1) ~ (x; -xi 
i=l 
where N is the number of samples in the interval, x, is the ith 
data sample in the interval, and xis the mean of the samples 
in the interval. If the variance calculation is replaced by the 
sum of the square amplitudes, similar results may be 
obtained. However, the variance calculation is used to gener-
ate the results presented. An upper limit for normal EMG 
background activity during REM sleep is defined as four 
times the 5th percentile of the variance observed during all 
NREM epochs. Normally, EMG tone during REM sleep 
should not exceed the lowest tone noted during NREM sleep, 
operationalized here as the 5th percentile of the NREM EMG 
variance. To identify activity likely to be abnormal, with 
reference to NREM EMG tone, a cut-off at 4 times the 5th 
percentile is initially tested. Other cut-offs may perform simi-
larly; e.g., 2 to 6 times the 5th percentile. The percentage of 
REM mini-epochs with variance above the selected threshold 
is computed as the new metric, referred to as the Supra-
Threshold REM EMG Activity Metric (STREAM). Since 
STREAM is the percentage of REM mini-epochs with vari-
ance above the selected threshold, it does not have units. A 
score for each subject is calculated as a REM sleep duration-
weighted average of the results from the 2 nights. 
Associations are tested for significance with the nonpara-
metric Spearman correlation coefficient rho, to avoid the 
assumption that underlying distributions of variables were 
normal. Receiver-operator curves were used to assess perfor-
mance of the new metric in comparison to the visual methods 
of Lapierre and Montplaisir. The level of statistical signifi-
cance is set at p<0.05. 
Results are as follows. The 23 subjects had a mean age of 
63± 10 ( s.d.) years and 12 were women. Table 1 below shows 
for each subject the RBD PSG score, EMG variance on each 
night, overall EMG variance score, STREAM on each night, 
overall RBD symptom score, and clinical impression based 
on criteria established by the International Classification of 
Sleep Disorders (ICSD). The mean STREAM was 
22.59±19.42. An example of EMG variance results during 
one 30-second epoch is shown in FIG. 3. The change in EMG 
variance through the night is illustrated in FIG. 4 for two 
representative subjects, one with and one without RBD based 
on clinical impression. For the patient without RBD (FIG. 4 
panel A, in red), the computed EMG variance is generally 
below the threshold during REM sleep, whereas for the 
patient with RBD (FIG. 4 panel B, in green), the EMG vari-
ance often exceeds the threshold. 
FIG. 3 graphically illustrates a thirty-second epoch of 
REM sleep recorded from subject 7 (upper panel), along with 
a corresponding plot of calculated EMG variance for each 
3-second mini-epoch (lower panel); LOC-A2 and ROC-Al 
are left and right electro-oculograms; Chinl-Chin2 is the 
submental EMG signal; C3-A2, C4-Al, O1-A2, and O2-Al 
are left central, right central, left occipital, and right occipital 
EEG derivations; the dashed line labeled "Threshold" is 
placed at 4 times the 5th percentile value of non-REM chin 
electromyographic variance for this particular subject; 
FIG. 4 graphically illustrates electromyographic variance 
computed over 3-second mini-epochs though the night (A) 
for a subject without a clinical diagnosis ofRBD (subject 17), 
and (B) for a subject with a clinical diagnosis ofRBD (subject 
2); NREM (blue) signifies values associated with non-REM 
mini-epochs; REM<THRES (red) indicates REM mini-ep-
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ochs with EMG variance values less than the 4 times the 
non-REM 5th percentile threshold, and REM>THRES 
(green) indicates REM epochs with EMG variance greater 
than the threshold; 
TABLE 1 
Summary ofRBD Measures for Each Subject* 
STREAM 
10 
derived PSG score (rho=0.42, p=0.048). RBD symptom 
scores derived from an International Criteria for Sleep Dis-
orders-based questionnaire are plotted against the computer-
generated STREAM score (A) and the visually-generated 
ICSD-Based RBD 
(2-night weighted Clinical Symptom 
Subject PSG Score STREAM Night 1 STREAM Night 2 average) Impression Score 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
11.86 
59.34 
57.45 
14.25 
43.14 
68.20 
50.92 
37.26 
5.88 
64.99 
59.16 
0.72 
9.14 
9.96 
46.30 
12.76 
1.98 
14.79 
10.24 
2.03 
5.19 
3.64 
6.23 
8.82 
5.96 
14.67 
37.87 
45.79 
50.28 
47.83 
26.43 
21.65 
54.62 
82.07 
1.98 
3.33 
7.21 
32.10 
2.91 
2.05 
21.26 
3.43 
5.45 
13.18 
8.05 
9.84 
11.25 
63.70 
15.27 
13.80 
54.00 
46.67 
52.06 
12.32 
15.97 
37.86 
59.90 
0.99 
15.54 
4.80 
27.34 
94.26 
2.86 
5.39 
4.45 
1.75 
4.76 
3.83 
11.06 
10.41 
38.28 
15.22 
23.39 
49.39 
49.55 
50.55 
20.13 
18.85 
44.26 
72.20 
1.43 
15.06 
5.71 
29.67 
26.18 
2.48 
14.99 
4.01 
3.28 
8.64 
5.38 
10.43 
0 
2 
2 
2 
2 
0 
0 
0 
2 
0 
0 
0 
2 
2 
0 
0 
0 
0 
0 
0 
0 
0.586 
0.623 
0.643 
0.586 
0.671 
0.308 
0.521 
0.29 
0.41 
0.65 
0.21 
0.353 
0.532 
0.35 
0.79 
0.592 
0.275 
0.21 
0.241 
0.208 
0.28 
0.583 
0.208 
*RED = REM sleep behavior disorder; PSG = polysomnogram; STREAM= supra-threshold REM electromyographic (EMG) 
activity metric; ICSD = International Classification of Sleep Disorders. 
PSG score (B). Subjects without a clinical diagnosis ofRBD As shown in FIG. 5, the variance-based STREAM corre-
lates well with the visually-derived PSG score for RBD sever-
ity (Spearmanrho=0.85, p<0.0001 ). The result is similar even 
if the analysis is confined to the 17 subjects with neurodegen-
erative disorders (rho=0.82, p=0.0001 ). A clinical impression 
ofRBD (probable or possible, n=9 subjects) is associated to a 
similar extent with both the computer-generated STREAM 
(Wilcoxon rank sum test, p=0.0089) and the visually-derived 
PSG score (p=0.0182). Subjects without a clinical diagnosis 
35 are indicated by circles ( o ), and the subjects with a clinical 
diagnosis of possible or probable RBD are indicated by 
crosses (x). Two outliers with high STREAM and low RBD 
symptom scores appear in FIG. 7A. Review of these poly-
sonmograms shows that in one case, the EMG channel used 
of RBD are indicated by circles ( o ), and the subjects with a 
clinical diagnosis of possible or probable RBD are indicated 
by crosses (x); 
40 by the algorithm shows relatively invariant, high activity 
throughout Night 1 that may be in part artifactual. In the 
second case, REM sleep is particularly difficult to score 
because it often resembled wakefulness. Such challenges can 
be common in a sample of patients with RBD. Elimination of 
45 those two outliers from the analysis improves the correlation 
between the STREAM and RBD symptom score (rho=0.67, 
p=0.0008). FIG. 6 shows that both the STREAM and the PSG score 
effectively separate subjects with and without an ICSD-based 
clinical impression of probable or possible RBD. Using the 
optimal threshold levels (12% for the PSG score and 14% for 50 
the EMG variance score) the methods have sensitivities of 
89% for the PSG score and 100% for the STREAM, and 
specificity of71 %, with 78% (18 of the 23) patients classified 
correctly using the PSG score and 83% (19 of 23) patients 
classified correctly using the STREAM. Panel A illustrates 55 
the computer-generated EMG variance score and Panel B 
illustrates the visually-generated PSG score (B), where both 
show similar ability to separate subjects for whom RBD was 
considered probable or possible (1) or unlikely (0) by clini-
cians who interviewed and examined the subjects; box plots 60 
show median, 25th and 75th percentiles as horizontal lines; 
the whiskers extend from the box out to 1.5 times the inter-
quartile range of the data; the'+' marks show outliers; panel 
(B) is adapted from methods and described in Example A. 
As depicted in FIG. 7, the RBD symptom score correlates 
to a similar extent, though not strongly, with the computer-
generated STREAM (rho=0.42, p=0.046) and the visually-
Both the STREAM and the PSG score can be used as 
metrics for identifying patients with RBD. A graphical 
method of summarizing the detection performance obtained 
with these metrics is to plot a receiver operating characteristic 
(ROC) curve, which summarizes the tradeoffbetween sensi-
tivity and specificity for various threshold levels of the metric. 
Sensitivity represents the probability of detecting RBD when 
it is present, and specificity represents the probability of not 
detecting RBD when it is actually absent. An ROC curve 
comparing the empirical detection performance of the 
STREAM with the PSG score, for a range of possible thresh-
old values on each measure, reveals similar efficacy for the 
two approaches, as shown in FIG. 8. FIG. 8 graphically illus-
trates the receiver-operator characteristic (ROC) curves for 
the STREAM and the visually-generated PSG score, suggest-
ing similar diagnostic utility for the two approaches; the area 
under the ROC curves computed using the trapezoidal 
65 method is 0.84 for STREAM and 0.73 for the PSG score. 
FIG. 9 graphically illustrates that the STREAM during 
REM sleep on night 1 correlates with STREAM on night 2 
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(rho=0.53, p=0.0098); subjects without a clinical diagnosis of 
RBD are indicated by circles ( o ), and the subjects with a 
clinical diagnosis of possible or probable RBD are indicated 
by crosses (x). Among all subjects, the computed STREAM 
on Night 1 correlates well with the STREAM on Night 2 
(rho=0.53, p=0.0098; FIG. 9A); however, this correlation is 
not as high as that observed for Night 1 and Night 2 visually-
derived PSG scores (rho=0.92, p<0.0001 ). The score from the 
second night, in comparison to that of the first night, seems to 
show stronger associations with clinical measures. Specifi-
cally, the second night STREAM effectively separates sub-
jects with and without an ICSD-based clinical impression of 
probable or possible RBD (Wilcoxon rank sum test, 
P=0.0028), whereas the first night STREAM does not (Wil-
coxon rank sum test, P=0.361, FIG. 9B). Similarly, the sec-
ond night STREAM shows a significant correlation with the 
RBD symptom score (rho=0.52, P=0.011 ), but the first night 
STREAM does not (rho=0.18, P=0.409, FIG. 9C). 
The value of the specific EMG frequency content used to 
compute STREAM is demonstrated by repeating the analyses 
using narrower, digitally filtered EMG frequency bands. The 
results, surmnarized in Table 2 below, suggest that the 
STREAM computed from lower frequency components of 
the EMG signal may provide a better association with clinical 
measures. 
TABLE2 
12 
in-home sleep studies, where objective evidence for RBD 
may improve assessment of patients suspected to have RBD, 
conditions strongly associated with RBD (such as Parkin-
son's disease, multiple system atrophy, and narcolepsy), or 
5 sleep disorders sometimes associated with RBD (such as 
restless legs syndrome and obstructive sleep apnea). 
Some previous attempts to quantify visual scoring of REM 
EMG activity have focused on bursts of phasic REM activity. 
"Phasic" refers to rapid eye movements during REM sleep. 
10 Such approaches that focus on phasic bursts of muscle activ-
ity have identified 5.0 to 12.5% of phasic REM sleep as 
containing these bursts. The STREAM often identifies higher 
proportions of REM sleep as having excessive tone, even in 
most subjects without RBD, and the percent of mini-epochs 
15 thus identified on any given night reached a maximum of 
81 %. These observations suggest that STREAM may assess 
bursts of activity (see FIG. 3) somewhat smaller in amplitude 
than those assessed using visual scoring methods. One impor-
tant advantage of STREAM in comparison to other 
20 approaches is that it obviates the need for somewhat arbitrary 
distinction of tonic and phasic types of motor activity. 
Other features of the present methods employing the auto-
mated algorithm that may facilitate assessment ofRBD fea-
tures include the automatic identification of a scoring thresh-
old specific to each subject, based on his or her lowest NREM 
Dependence of STREAM, and its Associations with Clinical Measures, on EMG Frequency. 
Spearman 
IC SD-Based RBD Symptom Score Correlation of 
EMG STREAM Clinical Impression (Spearman Correlation) 1st and 2nd 
Frequency Combined Nights (Rank Sum Test) P - value rho P - value Night STREAM 
Content Hz mean± SD Comb. !"Night 2nd Night Comb. !"Night 2nd Night rho (p - value) 
10-70 22.59 ± 19.42 0.0089 0.3610 0.0028 0.42 (0.046) 0.18 (0.4086) 0.52 (0.0111) 0.53 (0.0098) 
10-14.9 23.58 ± 20.62 0.0128 0.2439 0.0128 0.60 (0.0026) 0.39 (0.0650) 0.60 (0.0025) 0.71 (0.0002) 
15-19.9 22.50 ± 18.24 0.0153 0.5923 0.0061 0.48 (0.0194) 0.24 (0.2704) 0.45 (0.0296) 0.42 (0.0461) 
20-24.9 23.38 ± 18.08 0.0253 0.7290 0.0051 0.39 (0.0639) 0.11 (0.6277) 0.47 (0.0244) 0.39 (0.0680) 
25-29.9 27.98 ± 20. 74 0.0215 0.5923 0.0128 0.38 (0.0768) 0.04 (0.8402) 0.45 (0.0314) 0.49 (0.0180) 
30-34.9 30.33 ± 22.99 0.0215 0.3289 0.0128 0.38 (0.0755) 0.12 (0.5804) 0.43 (0.0405) 0.58 (0.0045) 
35-39.9 29.90 ± 23.51 0.0547 0.3289 0.0215 0.29 (0.1745) 0.15 (0.4922) 0.39 (0.0635) 0.77 (<0.0001) 
40-44.9 29.31 ± 23.11 0.0631 0.3610 0.0253 0.28 (0.1951) 0.08 (0.7013) 0.37 (0.0842) 0.78 (<0.0001) 
45-49.5 30.29 ± 23.01 0.0726 0.3610 0.0182 0.27 (0.2208) 0.10 (0.6551) 0.42 (0.0456) 0.78 (<0.0001) 
50-54.9 30.15 ± 22.61 0.0631 0.2439 0.0153 0.27 (0.2102) 0.15 (0.4994) 0.40 (0.0579) 0.83 (<0.0001) 
55-59.9 29.26 ± 23.15 0.0298 0.2193 0.0182 0.32 (0.1393) 0.15 (0.4808) 0.39 (0.0635) 0.81 (<0.0001) 
60-64.9 29.10 ± 23.52 0.0298 0.1227 0.0182 0.32 (0.1419) 0.17 (0.4284) 0.38 (0.0723) 0.83 (<0.0001) 
65-70 31.41 ± 23.85 0.0406 0.2193 0.0253 0.31 (0.1582) 0.13 (0.5558) 0.37 (0.0824) 0.84 (<0.0001) 
Embodiments of the present methods applied to the sample 
of patients with neurodegenerative disorders and control sub-
jects demonstrates that computerized analysis ofEMG vari-
ance during sleep quantifies polysonmographic evidence of 
RBD about as effectively as did a previously validated and 
commonly used visual scoring method. Both approaches 
appear to be effective in separating subjects with RBD from 
subjects without RBD. Major differences between the present 
methods employing computerized analysis as compared to 
visual RBD scoring, include the following: the present meth-
ods produce results in seconds rather than 1-3 hours for typi-
muscle activity. A subject's discomfort, restlessness, periodic 
leg movements, sleep apnea, or immobility (e.g., secondary 
50 to Parkinson's disease) could well affect average EMG vari-
ance. So could the quality of the connection between the 
EMG electrode and the skin over the muscle to be recorded. 
Hence, the REM EMG-scoringthresholdmay be based on the 
55 5
th percentile (low end) of the non-REM variance for the 
specific individual and his or her specific sleep study to assure 
that only minimum non-REM muscle tone during quiet sleep 
is used in all cases to determine the threshold for excessive 
REM sleep muscle tone. 
cal visual scoring; no previous experience in specialized RBD 60 
scoring is required for the present methods; the present meth-
ods may provide substantial cost savings; and the present 
methods may eliminate concerns over test-retest, inter-scorer, 
The so-called "first night effect" in polysonmography may 
affect REM sleep prominently and might explain the obser-
vation that the second night of polysonmography, in compari-
son to the first night, seems more useful in automatic assess-
ment for RBD. The original approach was to combine data or inter-laboratory reliability. The automatic computation of 
STREAM may be used in research settings requiring quanti-
fication of polysonmographic evidence for RBD. The algo-
rithm also may prove useful in clinical laboratory-based or 
65 from the 2 nights because REM sleep can be brief or difficult 
to score in older patients and especially those with neurode-
generative conditions. Two nights of diagnostic recording are 
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already advocated by some for patients suspected to have 
parasonmias. The present data support this approach, or else 
a habituation night of unrecorded sleep in a laboratory setting 
prior to the actual recording. 
14 
metric to assess EMG variance where this metric may be used 
alone or in conjunction with results from visual scoring, bed 
partner-rated RBD symptom scores, and/or clinical assess-
ments by sleep medicine specialists. 
The present methods correlate well with visual quantitative 
scoring methods. Nocturnal polysonmograms are acquired 
for each subject. A computer algorithm calculates the vari-
ance of the chin EMG during all 3-second mini-epochs, and 
compares variances during REM sleep to a threshold defined 
10 by variances during quiet non-REM (NREM) sleep. The per-
centage of all REM mini-epochs with variance above this 
threshold creates a metric, which is referred to as the supra-
threshold REM EMG activity metric (STREAM) for each 
subject. The STREAM correlates highly with the visually-
Several modifications to the EMG variance algorithm are 5 
possible. For example, the decision to use four times the 
non-REM 5th percentile for EMG variance as the threshold 
during REM sleep produces a reasonably wide spread of 
results between subjects with and without RBD, but other 
thresholds may be used to increase or decrease the spread. 
Moreover, whereas one chin EMG derivation is used for each 
subject, more selective attention to the derivation with the 
best signal quality may improve results, for example as sug-
gested by the review of outlier data. Alternative sites, in 
addition to or in combination with the chin site, may also be 
used for recording the surface EMG. The chin can be a good 
initial choice because the differences in muscle tone during 
REM and NREM sleep at this site can be greater than those 
recorded over muscles in any extremity. For example, explo-
ration of other sites shows a correlation with clinical mea-
sures for the left anterior tibialis as a recording site. Thus, the 
present algorithms and thresholds may be optimized for use at 
one or more sites. 
15 derived score for RBD severity (Spearman rho=0.87, 
P<0.0001). A clinical impression of probable or possible 
RBD was associated to a similar extent with both STREAM 
(Wilcoxon rank sum test, P=0.009) and the visually-derived 
score (P=0.018). An optimal STREAM cutoff identified 
20 probable or possible RBD with 100% sensitivity and 71 % 
specificity. The RBD symptom score correlated with both 
STREAM (rho=0.42, P=0.046) and the visual score 
(rho=0.42, P=0.048). The present methods and systems for 
assessment for RBD provide as much or more utility as com-In some embodiments, the present methods and systems 
may be applied to patients with idiopathic RBD. For example, 
patients with idiopathic RBD may develop one of the neuro-
degenerative conditions examined using the present methods 
and RBD manifestations in patients with and without neuro-
degenerative conditions are largely indistinguishable. In 
some embodiments, the present algorithm does not exclude 
EMG bursts at the termination of apneic events, and in other 
embodiments the method and algorithm performance may be 
enhanced if such EMG bursts are excluded. Additionally, in 
some embodiments specific EMG frequency bands may 
prove more useful than others. For example, the lower fre-
quency bands examined (e.g., 10 to 15 Hz) appear to be more 
useful, and frequencies lower than 10 Hz may perform better 
in some embodiments. 
The present disclosure also includes the following features. 
The patient and study-specific non-REM sleep EM G variance 
can be used to determine a threshold above which REM sleep 
EMG tone should not normally rise; that this level of activity 
is computed automatically by the algorithm; and that the 
diagnosis of RBD ( or identification of REM sleep without 
atonia) can be facilitated by analysis of the frequency with 
which the EMG minimum variance threshold established dur-
ing non-REM sleep is in fact exceeded during REM sleep. In 
some embodiments, the effective quantitative analysis of the 
EMG during REM sleep can be performed with one single 
assessment of EMG activity, rather than the two separate 
assessments that are employed visually in traditional, manual 
assessments of polysonmograms for evidence ofRBD. Other 
approaches-either non-quantitative as described in the 
International Classification of Sleep Disorders or quantitative 
but visual and subjective as described by LaPierre and Mont-
plaisir (Neurology, 1992)-all rely on separate assessments 
25 pared with the more time-consuming manual visual scoring 
approach. 
The present methods and systems include providing EMG 
scoring methods in order to distinguish RBD patients from 
control subjects. In some embodiments, these methods may 
30 be used to validate other methods or may be performed in 
combination with features of other quantitative methods as 
described by Lapierre 0, Montplaisir J., "Polysomnographic 
features of REM sleep behavior disorder: Development of a 
scoring method," Neurology 1992; 42:1371-1374, including 
35 those methods as described in Examples 1 and 2. For 
example, the present methods and systems may be combined 
with those described by Consens F B, Chervin R D, Koeppe 
RA et al., "Validation of a poly sonmographic score for REM 
sleep behavior disorder," Sleep 2005; 28(8):993-997 that 
40 demonstrate the diagnostic validity of the polysomnographic 
score. The present methods therefore may serve to augment or 
replace limitations of such visual scoring methods, where 
using visual scoring methods alone is hampered by subjec-
tivity, time-consumption ( typically adding 1-3 hours to total 
45 scoring time), expense, and where visual scoring is feasible 
only after considerable practice by an experienced technolo-
gist. 
The present methods and systems include a computer algo-
rithm that compares EMG variance during REM and NREM 
50 sleep and generates a score predictive of RBD symptoms, 
ICSD-based diagnoses, and visual polysonmographic find-
ings. These methods and systems reduce time and labor and 
increase reliability of efforts to identify or quantify RBD 
features on polysonmography. These methods and systems 
55 may be used for clinical diagnosis or assessment for RBD or 
for evaluation of patients who have conditions in which the 
risk ofRBD is increased. In some cases, the present methods 
and/or combination of methods can provide EMG scoring 
that distinguishes RBD patients from control subjects. 
of REM sleep-associated discrete bursts ofEMG activity and 
baseline EMG tone. In the present methods, one single syn-
thesized quantitative assessment of EMG variance during 
REM sleep may be as effective as the more complicated dual 60 
approach, which appears to be unnecessary. EXAMPLE 1 
The present methods include polysonmographic assess-
ment for REM sleep behavior disorder (RBD). These meth-
ods may be used in conjunction with visual scoring methods 
which are reliable but require slow, labor-intensive visual 65 
scoring of surface electromyogram (EMG) activity. The 
present methods and systems may include a computerized 
Example 1 illustrates quantitative visual scoring methods 
that may be used comparatively or in conjunction with the 
present methods that include an algorithm that compares 
EMG variance during REM and NREM sleep and generates a 
score predictive ofRBD symptoms, ICSD-based diagnoses, 
US 7,996,076 B2 
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and visual polysomnographic findings. These visual scoring 
methods include methods and modifications of the methods 
as described by Consens F B, Chervin RD, Koeppe RA et al., 
"Validation of a poly somnographic score for REM sleep 
behavior disorder," Sleep 2005; 28(8):993-997. ICSD 
Criterion 
A 
B or 
C-1 
C-2 
C-3 
D 
E 
16 
TABLE3 
Questionnaire That Bed Partners Used 
to Rate The Severity ofRBD. 
Scale 
1-5 
1-5 
1-5 
1-5 
1-5 
1-4 
1-3 
Question item 
My bed partner has a problem with violent 
or injurious behavior during sleep 
My bed partner moves his/her arms, legs, 
body during dreams 
My bed partner's behavior during sleep is 
harmful or potentially harmful 
My bed partner appears to act out dreams 
My bed partner's behaviors during sleep 
disrupt his/her sleep 
How much discomfort does your bed part-
ner's behavior cause you? 
What is the duration of your bed partner's 
symptoms? 
In Table 3, RBD refers to REM (rapid eye movement) sleep 
behavior disorder; ICSD, International Classification of 
Sleep Disorders. Scales for itemsA-C3 ranged from (1) never 
to (5) nightly; for item D, from no discomfort (1) to severe 
discomfort (4); for item E, from less than 1 month (1) to more 
than 6 months (3). 
Sleep studies include the following. All subjects are stud-
ied on 2 consecutive nights with laboratory-based polysom-
nography (PSG). Digital recordings include electroencepha-
logram (C3-A2, C4-Al, O1-A2, O2-Al by International 
10-20 system), chin EMG, electrooculogram, electrocardio-
gram, snoring, respiratory effort using piezoelectric belts 
over the chest and abdomen, and airflow at the nose and 
mouth using thermocouples. Bilateral surface EMGs from 
the arms (with electrodes placed over the forearm extensor 
compartment) and legs (with electrodes placed over the ante-
Subjects are selected as follows. Patients have diagnoses of 
multiple system atrophy (MSA), Parkinson disease (PD), 
dementia with Lewy bodies (DLB), progressive supranuclear 
palsy (PSP), or sporadic olivopontocerebellar atrophy 
(OPCA). Diagnoses are made by board-certified neurologists 10 
who specialize in neurodegenerative disorders. The patients 
are volunteer participants in a National Institutes of Health-
funded study of RBD in the a-synucleinopathies, including 
MSA, PD, and DLB. They are recruited from the ataxia, 
movement disorders, and cognitive disorders clinics at the 15 
Department of Neurology, University of Michigan. Subjects 
are recruited sequentially from these clinics if they met cri-
teria for diagnosis; indicated interest in the research study; 
and signed a consent form or, if demented, had a consent form 
cosigned by the next of kin or legal guardian. The patients had 20 
not previously been referred to a sleep disorders center, and a 
consultation with sleep experts is included as part of their 
study. Patients with PSP are included to have a group of 
patients with a neurodegenerative disorder causing parkinso-
nian symptoms unassociated with RBD, for comparison with 25 
the MSA, DLB, and PD patients. For comparison to patients 
with neurodegenerative disorders, normal control subjects 
with a similar age and sex distribution are included. The 
controls are individuals not genetically related to the patients 
but still interested in participating in the study. Control sub- 30 
jects have no neurodegenerative disease. They are recruited 
from the community and not specifically selected for any 
sleep complaints. For the most part they shared the same 
environment as the subjects (significant other, friend, church 
member, etc.). 
The clinical interview of patients is as follows. Subjects are 
admitted to the General Clinical Research Center Sleep Dis-
orders Laboratory, where they undergo a complete history 
and physical examination. A comprehensive evaluation of 
their sleep history is performed by either of 2 neurologists 40 
who are each diplomates of the American Board of Sleep 
Medicine and the American Board of Psychiatry and Neurol-
ogy. Based on the International Classification of Sleep Dis-
orders (ICSD) entry for RBD, the physicians generate an 
overall clinical impression of whether the likelihood of RBD 45 
is probable, possible, or unlikely. Because evidence-based 
definitions of these states do not exist, this rating represents a 
Likert scale only. In general, patients with a history of fre-
quent, clear dream enactment are rated as "probable," those 
with no history of such episodes as "unlikely," and those with 50 
behavioral episodes that are not clearly repeated dream enact-
ment are rated as "possible." At the time of the interview, the 
clinicians are masked to questionnaire and polysomno-
graphic results but not to any medical history. 
35 riortibialis muscles) are also recorded. Oxyhemoglobin satu-
ration is monitored by pulse oximetry and behavior is moni-
tored by continuous video observation. Experienced 
polysomnographic technologists masked to patients' diag-
noses apply the electrodes and continuously monitor the 
The questionnaire information includes the following. All 55 
subjects received a questionnaire to be completed by the bed 
partner. Symptom items reflected each criterion listed in the 
ICSD; see Table 3 below. When no partner is available, the 
subjects themselves are asked to complete the questionnaire. 
Responses for symptom items, which have different numbers 60 
of response levels in some cases, are expressed as a propor-
tion of the maximal item value: each response therefore var-
ied from O (denied) to 1 (fully endorsed). For example, a 
response of 2 on item E is converted to a value of 0.50, 
whereas a response of 2 on item B is converted to a value of 65 
0.25. The average score on all question items then was used as 
the overall RBD symptom score. 
recordings. 
Scoring includes the following. Polysomnographic tech-
nologists use 21-inch-high resolution (1600x1200 pixel) 
computer monitors and standard techniques 17 to score 
manually all recordings for sleep stages, limb movements and 
respiratory events. One senior registered polysomnographic 
technologist masked to patients' clinical data scores PSG 
measures ofRBD according to the method described by Lapi-
erre 0, Montplaisir J., "Polysomnographic features of REM 
sleep behavior disorder: Development of a scoring method," 
Neurology 1992; 42: 1371-1374 (RPSM). Lapierre andMont-
plaisir suggest that patients with RBD may be distinguished 
from normal control subjects with 2 measurements: the pro-
portion of 20-second REM sleep epochs that contain a pre-
dominance of abnormally elevated background chin muscle 
tone (tonic component), and the proportion of2-secondmini-
epochs (within 20-second REM sleep epochs) that show 
bursts of EMG activity (phasic component). The instant 
visual methods employed identical measures except that the 
epochs to assess tonic activity are 30 seconds in duration (a 
more widely used standard), and the mini-epochs to assess 
phasic activity are 3 seconds in duration. Following the 
RPSM, each REM sleep epoch is scored as tonic or atonic 
depending upon whether tonic chin EMG activity is present 
for more or less than 50% of the epoch. No particular exclu-
sions are made when physiologic evidence for REM sleep 
may not have occupied the entire epoch, or when an arousal 
( for example, after an apnea) occurred during an epoch scored 
as REM sleep. After disruption of REM sleep by movement 
arousals or by artifact, the continuation of rapid eye move-
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ments, increased motor activity with erratic behavior, or 
incongruous vocalizations are used to identify reemergence 
ofREM sleep if the electroencephalogram signal is consistent 
with REM sleep and alpha frequencies were absent. 
Analysis includes the following. Data from both nights of 
observation are used to calculate a single weighted mean for 
each of the 2 RBD measures. For example, if 60 epochs of 
REM sleep are recorded on the first night and 30 epochs on 
the second night, the first night is weighted by a factor of 2 
relative to the second night. If 20% of the 60 epochs recorded 
on the first night and 50% of the 30 epochs on the second night 
are abnormal, the weighted average is (0.2x60+0.5x30)/(60+ 
30)=0.3 or 30%, and not simply the average of20% and 50%, 
which is 35%. This approach is identical to analyzing the data 
of the 2 nights as if they were obtained from 1 long night. 
5 
10 
The RBD measure for the proportion of epochs containing 15 
elevated muscle tone and the measure for the proportion of 
miniepochs containing burst activity are then averaged to 
obtain an overall RBD polysomnographic score. This score is 
used in the main analyses: nonparametric Spearman correla-
tions that test for associations with the RBD symptom score, 20 
and t tests that assess for associations with the ICSD-based 
clinical impression. The level of significance is set at P<0.05. 
18 
TABLES 
Polysornnograhic RBD Scores, along with Component 
Scores: Percentage Phasic and Tonic Measures 
All subjects RBD 
Polysomno- subjects* subjects* Non-RBD 
graphic (n-9) (n-14) P value 
RBD Score 25.89 ± 24.22 39.81 ± 21.88 16.94 ± 21.85 
Phasic, % 22.10 ± 17.87 29.33 ± 19.10 17.46 ± 16.02 
Tonic,% 29.67 ± 37.53 50.29 ± 41.35 16.42 ± 29.13 
Ttest 
0.02 
0.12 
0.03 
Data are presented as mean±SD. *REM (rapid eye move-
ment) sleep behavior disorder (RBD) defined by clinical 
impression of possible or probable diagnosis, based on defi-
nition in International Classification of Sleep Disorders. 
FIG.10 graphically illustrates a quantitative visual scoring 
method where the REM (rapid eye movement) sleep behavior 
disorder (RBD) polysomnographic score (PSG Score) is plot-
ted against the International Classification of Sleep Disor-
ders-based clinical impression of RBD presence (1) or 
absence (0). Plots show median scores (midline), mean 
(cross), and 10th, 25th, 75th, and 90th percentiles. The poly-
somnographic RBD score shows an association with the 
Results include the following. The quantitative visual scor-
ing method is applied to 23 patients (12 women) aged48 to 81 
years (mean 63±10 [SD]). Seventeen subjects had neurode-
generative diseases, including 1 with OPCA, 2 with DLB, 3 
with PSP, 5 with MSA, and 6 with PD. Six normal control 
subjects (5 women) are aged 49 to 74 years (mean 53±4). 
Only 1 control subject had no partner and therefore com-
25 ICSD-based clinical impression of RBD (t test, P=0.023; 
FIG. 10 ). The tonic component of the overall score also shows 
an association with clinical impression ofICSD (P=0.031). 
The phasic component is in the expected direction but is not 
pleted her own questionnaire. 
30 Table 4 lists subject ages, sexes, diagnoses, and scores for 
each RBD measure: polysomnographic, symptom-based, and 
overall clinical impression. Only 2 subjects are thought by 
clinicians to have "possible RBD," and these subjects there-
fore are combined with the "probable" group for analyses. 
The mean RBD polysomnographic score and component 
measures are listed in Table 5. 
statistically significant (P=0.122). 
FIG. 11 graphically illustrates a quantitative visual scoring 
method where the REM (rapid eye movement) sleep behavior 
disorder (RBD) polysomnographic score (PSG score) is plot-
ted against the RBD symptom score derived from bed partner 
questionnaires (Quest). The overall polysomnographic RBD 
Subject Sex Age,y 
M 81 
2 M 74 
3 M 68 
4 M 65 
5 F 52 
6 F 74 
7 M 60 
8 M 64 
9 F 48 
10 M 53 
11 M 65 
12 F 61 
13 F 69 
14 F 76 
15 M 66 
16 M 78 
17 F 52 
18 F 58 
19 F 49 
20 M 54 
21 F 53 
22 F 57 
23 F 74 
TABLE4 
35 
score shows a significant association with the RBD symptom 
score (Spearman rho=0.42, P=0.048; FIG. 11), as did the 
Summary of Demographic, Diagnostic, and RBD Data. 
RBD RBD ICSD-based 
polysomnographic symptom clinical Medications 
Diagnosis score score impression* at time of study 
PD 11.85 0.59 0 L/C, venlafaxine 
PD 59.33 0.62 2 L/C 
PD 57.45 0.64 2 L/C, buspirone 
PD 14.25 0.59 2 L/C, pramipexole 
PD 43.14 0.67 2 L/C, pramipexole 
PD 68.19 0.31 0 
MSA 50.92 0.52 SSRI 
MSA 37.36 0.29 0 
MSA 5.88 0.41 0 
MSA 64.98 0.65 2 SSRI 
MSA 59.16 0.21 0 
PSP 0.72 0.35 0 
PSP 9.14 0.53 
PSP 9.96 0.35 0 SSRI 
DLB 46.29 0.79 2 
DLB 12.75 0.59 2 SSRI: L/C 
OPCA 1.98 0.28 0 
NC 14.78 0.21 0 
NC 10.24 0.24 0 
NC 2.03 0.21 0 bupropion 
NC 5.19 0.28 0 
NC 3.64 0.58 0 SSRI 
NC 6.23 0.21 0 
*Clinical impression: likelihood of REM (rapid eye movement) sleep behavior disorder (RBD) was probable 2, possible 1, or 
unlikely 0. PD refers to Parkinson disease; MSA, multiple system atrophy; PSP, progressive supranuclear palsy; DLB, dementia 
with Le~ bodies; OPCA, sporadic olivopontocerebellar atrophy; NC, normal control; L/C, levodopa/carbidopa; SSRI, selective 
serotonin reuptake inhibitor. 
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separate tonic and phasic components of the polysomno-
graphic score (rho=0.49, P=0.018, and rho=0.43, P=0.042, 
respectively). 
20 
tation could reduce the effectiveness of either visual, Lapierre 
and Montplaisir-based scoring ofRBD features or automated 
STREAM. An automatic sleep staging algorithm could 
The ICSD-based clinical impression ofRBD shows a close 
association with RBD symptom scores (P<0.0001 ). If a cutoff 5 
of 10 or more percentage points on the polysomnographic 
RBD score is used to indicate RBD ( as suggested by receiver-
operator curves), the RPSM in comparison with the clinical 
impression gold standard shows a sensitivity of 89% and a 
specificity of 57%. 
Each of the 23 subjects had some scored REM sleep on 
each of the two nights, though the amount ranged from 1.5 
minutes to 174.5 minutes. Nonetheless, the tonic, phasic, and 
combined (averaged) measures on night 1 correlate closely 
with the same measures on night 2 (rho=0.73, P<0.0001; 15 
rho=0.83, P<0.0001; and rho=0.92, P<0.0001, respectively). 
potentially be used to eliminate inter-rater reliability con-
cerns in REM vs. NREM scoring. The potential for inad-
equate reliability, and the length of time (up to several hours) 
required to score nocturnal PSGs with the visual technique, 
may be reduced also by using the present methods and sys-
tems that include a computer algorithm that compares EMG 
10 
variance during REM and NREM sleep and generates a score 
predictive of RBD symptoms, ICSD-based diagnoses, and 
visual polysomnographic findings. 
Another potential limitation of quantitative visual scoring 
arises from combining the percentage of phasic and percent-
age of tonic measures into 1 overall polysomnographic RBD 
score. This approach seems logical, when the numbers of 
studied patients remain somewhat limited, but 1 measure 
could potentially obscure physiologically informative infor-
mation in the other. Another potential limitation, as in any 
initial cross-sectional study, is that results could be sensitive 
to potential confounds, difficult to assess within the current 
sample size, such as age, sex, duration of illness, severity of 
parkinsonian symptoms, or medication status. 
RPSM for quantitative visual analysis of polysomno-
graphic RBD features is valid and provides test-retest reli-
ability. The method may be useful in both clinical and 
research settings. Cutpoints of 10% or more of REM sleep 
spent with elevated background EMG tone or phasic burst 
The quantitative visual scoring measures of RBD poly-
somnographic features are valid markers for the target sleep 
disorder. Whether RBD is defined by ICSD-based clinical 
impressions or by bed-partner symptom ratings, the overall 20 
polysomnographic RBD measure shows an association with 
the presence of the disorder and with its severity. Decompo-
sition of the polysomnographic RBD measure into its com-
ponent parts-tonic and phasic scores-generates similar 
results. In addition, the high correlation between polysomno- 25 
graphic RBD measures on nights 1 and 2 reveals little test-
retest variability. Together, these results suggest that the Lapi-
erre and Montplaisir approach to quantification of RBD 
polysomnographic severity is a valid and reliable tool in 
clinical practice and research. 
The previous edition of the ICSD (1992) does not require 
polysomnographic evidence to meet minimal criteria for the 
diagnosis of RBD. This supports the use of sleep-specialist 
clinical impressions and symptom-rating scales as "gold-
standards" against which polysomnographic measures are 35 
compared. The new ICSD (2005) requires polysomnographic 
features to confirm the diagnosis. Nevertheless, these poly-
somnographic features remain, as in the 1992 edition, sub-
jectively determined. A more quantitative method, such as the 
visual REM sleep polysomnographic scoring method 40 
(RPSM), helps to standardize RBD determinations between 
clinical laboratories, research sites, and polysomnographers 
30 activity suggests a diagnosis ofRBD. This quantitative visual 
method to assess the severity of RBD polysomnographic 
features is valid and reliable in patients at risk for RBD 
because of neurodegenerative disorders. 
at any specific site. Using these methods, the cutpoint of 10% 
(average of tonic REM percentage and phasic REM percent-
age) appears to be optimal to define findings suggestive of 45 
RBD. However, larger sample sizes may more precisely 
define an alternate or better cutpoint. Investigation of more 
healthy individuals may better characterize the normal range 
of values generated by the RPSM. However, in clinical prac-
tice, the distribution of polysomnographic RBD scores is 50 
more likely to be unimodal than bimodal, and clinical judg-
ment based on clinical findings along with laboratory results, 
without a strict cutpoint, may be most useful. In research 
studies, a well-defined objective cutpoint may help identify a 
homogenous study sample and improve generalizability of 55 
results. 
EXAMPLE2 
Example 2 illustrates quantitative visual scoring methods 
that may be used comparatively or in conjunction with the 
present methods that include an algorithm that compares 
EMG variance during REM and NREM sleep and generates a 
score predictive ofRBD symptoms, ICSD-based diagnoses, 
and visual polysomnographic findings. These visual scoring 
methods include methods and modifications of the methods 
as described by Lapierre 0, Montplaisir J., "Polysomno-
graphic features of REM sleep behavior disorder: Develop-
ment of a scoring method," Neurology 1992; 42: 1371-1374. 
Methods include the following. Patients who fulfill the 
diagnostic criteria of severe chronic RBD are selected. These 
patients were referred to the sleep clinic for nocturnal agita-
tion. They exhibit violent behavior during sleep, starting 
approximately 1 hour after sleep onset and recurring up to five 
times during the night. These episodes occurred 3 to 7 nights 
a week for 1 to 4 years. None of the patients reported confu-
sion upon arousal from these nocturnal events, but all 
reported frequent nightmares characterized mainly by threat-
ening situations in which they would either fight or flee. These 
nightmares are closely associated with motor behavior 
responsible for injuries ranging from bruises to wrist fracture. 
Five normal controls paired to RBD patients for age (aged 
A limitation of quantitative visual scoring is interscorer or 
intrascorer reliability. An important challenge in patients with 
a-synucleinopathies is to initially identify REM sleep, the 
first step in the RPSM. In practice, exceptions to 
Rechtschaffen and Kales or American Academy of Sleep 
Medicine (2007) scoring rules must sometimes be made to 
score REM periods with elevated electromyographic tone 
despite clear evidence of rapid eye movements and EEG 
activity consistent with REM sleep. It is not clear whether 
such exceptions can be made on a reliable basis by different 
scorers or upon rescoring by the same individual. This limi-
60 45 to 66 years, mean 58.4) are also included. These control 
subjects have no clinical evidence of sleep disturbance. In 
addition, seven patients with idiopathic periodic limb move-
ments in sleep (PLMS) are recorded as controls in order to 
compare PLMS distribution in REM and non-REM (NREM) 
65 sleep with that ofRRD patients. Patients and controls are free 
of psychiatric disorders and epilepsy and none used psycho-
tropic medication for at least 2 months before the study. 
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compare specific REM sleep features, since the hypothesis 
was that RHD patients exhibit more tonic and phasic activity 
during REM sleep. A paired t test (one-tailed) is used to 
compare data obtained in RBD patients before and aftertreat-
Investigation of each patient includes a complete neuro-
logic examination by a neurologist, a routine diurnal EEG, 
one all-night sleep EEG using Queen Square and parasagittal 
montages, and CT. In addition, auditory evoked potentials 
and blink reflexes are assessed to evaluate the integrity of 
brainstem structures. Results of the neurologic investigation 
were normal in every subject except for the presence of soft 
cerebellar signs in one patient. Since RBD had started at an 
early age ( 40 years) in this patient, MRI was performed; it 
revealed an Arnold-Chiari type I malformation. 
5 ment with clonazepam. A Wilcoxon-Mann-Whitney test is 
performed on variables not normally distributed. 
This scoring method shows sensitivity to treatment with 
clonazepam. An increased phasic submental EMG density 
occurs in RBD patients, but REM density is similar to that of 
RRD patients and controls had 2 nights of PSG recording. 
10 
controls. Clonazepam selectively decreases REM sleep pha-
sic activity but exerts no effect on REM sleep atonia. Periodic 
limb movements in sleep (PLMS) occur equally in both REM 
and NREM sleep in RBD patients, suggesting that normal 
suppression of PLMS in REM sleep is due to motor inhibi-
PSG investigation consists of a standard montage for scoring 
sleep stages: left and right electrooculograms, submental 
EMG, central ( C3-A2) and occipital ( O2-Al) EEG, and ECG. 
Left and right tibialis anterior EMGs are also recorded and 15 
PLMS are scored according to Coleman's criteria (Coleman 
RM, "Periodic movements in sleep (nocturnal myoclonus) 
and restless legs syndrome," In Guilleminault C, ed., Sleeping 
and waking disorders: indications and techniques, Menlo 
Park, Calif. Addison-Wesley, 1982:265-295). The PLMS 
20 index represents the number of periodic limb movements per 
hour of sleep. During the first night, a nasobuccal thermistor 
is used to rule out sleep apneas. Apnea is defined as the 
interruption of oral and nasal airflow for at least 10 seconds. 
None of the patients or controls exceeded five apneas per hour 
of sleep. Treatment consisted of clonazepam at dosages vary- 25 
ing from 0.5 to 2.0 mg given between 1 and 2 hours before 
bedtime. Two months after the onset of treatment, patients 
underwent two additional all-night PSG recordings. Seven 
idiopathic PLMS controls paired for age were also studied, in 
order to compare PLMS indexes in REM and NREM sleep 30 
with those ofRBD patients. 
Sleep stages are scored according to a modified version of 
the method of Rechtschaffen and Kales (Rechtschaffen A, 
Kales A A, "A manual of standardized terminology, tech-
niques and scoring system for sleep stages of human sub- 35 jects," Washington, D.C.: US Government Printing Office, 
Public Health Service, 1968) using 20-second epochs. Since 
muscle atonia is deficient in RBD patients, REM sleep is 
scored without submental EMG atonia. The occurrence of the 
first rapid eye movement is used to determine the onset of a 
REM sleep period. The termination of a REM sleep period is 40 
identified either by the occurrence of specific EEG features 
tion. 
The description of the invention is merely exemplary in 
nature and, thus, variations that do not depart from the gist of 
the invention are intended to be within the scope of the inven-
tion. Such variations are not to be regarded as a departure 
from the spirit and scope of the invention. 
What is claimed is: 
1. A method for diagnosing and assessing rapid eye move-
ment sleep behavior disorder (RBD) in a patient, comprising: 
measuring at least one physiological signal of the patient 
during at least one rapid eye movement (REM) sleep 
time interval and at least one non-rapid eye movement 
(NREM) sleep time interval; 
determining a REM variance for the physiological signal 
within the at least one REM sleep time interval and an 
NREM variance for the physiological signal within the 
at least one NREM sleep time interval; 
establishing a threshold based on the NREM variance; and 
calculating a percentage of REM sleep time intervals with 
variance above the threshold, where the steps of deter-
mining, establishing and calculating are executed by a 
computer processor. 
2. The method of claim 1, wherein the physiological signal 
is an electromyogram (EMG). 
3. The method of claim 1, wherein the physiological signal 
is an electrical potential generated by at least one muscle of 
the patient. 
4. The method of claim 3, wherein the at least one muscle 
is a chin muscle. 
(K complexes, sleep spindles, or EEG signs of arousal), or by 
the absence of rapid eye movements during nine consecutive 
20-second epochs. The same method is used to score REM 
sleep in normal subjects. 
5. The method of claim 1, wherein the at least one rapid eye 
45 movement (REM) sleep time interval is a plurality of succes-
sive time epochs. The tonic and phasic components of REM sleep are scored 
separately. Each 20-second epoch is scored as tonic or atonic 
depending on whether tonic chin EMG activity is present for 
more or less than 50% of the epoch. Two types of phasic 
activity characteristic of REM sleep are scored: REM density 50 
and phasic EMG density. REM density is defined as the 
percentage of 2-second mini-epochs of REM sleep contain-
ing at least one rapid eye movement. Phasic EMG density is 
scored from the submental EMG recording and represented 
the percentage of 2-second mini-epochs containing phasic 55 
EMG events. Those phasic EMG events are defined as any 
burst ofEMG activity lasting 0.1 to 5 seconds with an ampli-
tude exceeding four times the background EMG activity. 
These criteria are used to identify all EMG bursts that clearly 
contrast with the background activity. Short EMG bursts (less 
than 100 msec) are not counted, in order to exclude the 60 
repetitive discharge from a single motor unit that is found 
occasionally in normal individuals and in patients during 
REM sleep and is unaccompanied by any movement on the 
video recording. 
Statistics include the following. A paired t test (two-tailed) 65 
for independent variables is used to compare sleep variables 
of RBD and control subjects. A one-tailed t test is used to 
6. The method of claim 5, wherein the time epochs are 
about 3 seconds. 
7. The method of claim 1, wherein the measuring includes 
an automated method for distinguishing REM and NREM 
sleep time intervals. 
8. The method of claim 1, wherein determining at least one 
of the REM variance or the NREM variance includes using 
the formula: 
wherein: 
N 
CT= 1/(N -1) ~ (x; -xi 
i=l 
a is the variance, 
N is a number of samples in the time interval, 
x, is an ith sample of the signal in the time interval, and 
x is mean signal in the time interval. 
9. The method of claim 1, wherein determining at least one 
of the REM variance or the NREM variance includes deter-
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mining the sum of the square amplitudes of the physiological 
signal within the at least one REM sleep time interval. 
10. The method of claim 1, wherein establishing a thresh-
old based on the NREM variance includes: 
setting an upper limit for a physiological signal back- 5 
ground during REM sleep, wherein the upper limit is 
about two to about six times the 5th percentile of the 
NREM variance. 
11. The method of claim 10, wherein the upper limit is 
about four times the 5th percentile of the NREM variance. 
12. The method of claim 1, wherein the measuring at least 
one physiological signal of the patient includes signals from 
two or more nights. 
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partitioning the EMG signal into predefined time intervals; 
computing a variance for the EMG signal in each time 
interval using a computer processor, where the variance 
is a measure from a mean value of the EMG signal; and 
computing an indicator of RBD based on the variance 
measures from the EMG signal using a computer pro-
cessor. 
21. The method of claim 20, further comprising: 
establishing an abnormality threshold for the EMG signal 
during REM sleep based on variance measures observed 
during a non-REM portion of the EMG signal; and 
computing a percentage of when the REM portions of the 
EMG signal exceeds the abnormality threshold. 
13. The method of claim 1, wherein the measuring at least 
one physiological signal of the patient occurs following a 
habituation night of sleep by the patient. 
22. An automated method for diagnosing and assessing 
15 rapid eye movement sleep behavior disorder (RBD) in a 
patient, comprising: 
14. The method of claim 1, further comprising classifying 
the patient as an RBD candidate when the percentage of REM 
sleep time intervals with variance above the threshold 
exceeds the threshold during the REM sleep time interval. 
15. The method of claim 1, wherein measuring at least one 
physiological signal of the patient during at least one rapid 
eye movement (REM) sleep time interval and at least one 
non-rapid eye movement (NREM) sleep time interval 
includes filtering the at least one physiological signal. 
16. The method of claim 15, wherein the filtering removes 
a portion of the physiological signal having frequencies 
greater than about 15 Hz and retains a portion of the physi-
ological signals having frequencies less than about 15 Hz. 
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17. An automated method for diagnosing and assessing 30 
rapid eye movement sleep behavior disorder (RBD) in a 
patient, comprising: 
measuring a physiological signal of the patient during mul-
tiple sleep intervals; 
recording an electromyogram (EMG) signal while the 
patient is sleeping; 
partitioning the EMG signal into predefined time incre-
ments and calculating a variance measure for each time 
increment; 
identifying portions of the EMG signal which occurred 
during non-rapid eye movement (NREM) and rapid eye 
movement (REM) sleep; 
establishing an abnormality threshold for the EMG signal 
during REM sleep based on variance measures observed 
during a non-REM portion of the EMG signal; and 
computing a percentage of when the REM portions of the 
EMG signal exceeds the abnormality threshold using a 
computer processor. 
23. The method of claim 22 wherein establishing an abnor-
mality threshold further comprises selecting a variance mea-
sure at a fifth lowest percentile of variance measures observed 
during the non-REM portion of the EMG signal and setting 
identifying portions of the physiological signal which 
occurred during non-rapid eye movement (NREM) 
sleep and rapid eye movement (REM) sleep; and 
establishing a threshold for the REM portions of the signal 
using the NREM portions of the signal, where the estab-
lishing step is executed by a computer processor. 
35 the abnormality threshold to about four times the selected 
varrnnce measure. 
18. The method of claim 17, wherein the measuring 
includes measuring an electromyogram (EMG) signal of the 
patient. 
19. The method of claim 17, wherein establishing a thresh-
old includes: 
establishing an abnormality threshold for the EMG signal 
during REM sleep based on variance observed during 
the NREM sleep portion of the EMG signal; and 
computing a percentage of when the REM portions of the 
EMG signal exceed the abnormality threshold. 
20. An automated method for diagnosing and assessing 
rapid eye movement sleep behavior disorder (RBD) in a 
patient, comprising: 
capturing a electromyogram (EMG) signal while the 
patient is sleeping; 
40 
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24. The method of claim 22, wherein calculating the vari-
ance measure includes using the formula: 
wherein: 
N 
CT= 1/(N -1) ~ (x; -xi 
i=l 
a is the variance, 
N is a number of samples in the time increment, 
x, is an ith signal in the time increment, and 
x is mean signal in the time increment; 
or, 
determining the sum of the square amplitudes of the signals 
within the time increment. 
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